Page 1 | Search Results | Hematology, ASH Education Program

1-20 of 130

Sort by

Sort Order Select

Journal Articles

Opportunities for immunotherapy in childhood acute myeloid leukemia

Adam J. Lamble, Sarah K. Tasian

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 218–225.

https://doi.org/10.1182/hematology.2019000357

Published: 2019

Journal Articles

Optimal disease management and health monitoring in adults with sickle cell disease

Jo Howard, Swee Lay Thein

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 505–512.

https://doi.org/10.1182/hematology.2019000055

Published: 2019

Journal Articles

Clonal evolution and immune evasion in posttransplantation relapses

Luca Vago

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 610–616.

https://doi.org/10.1182/hematology.2019000005

Published: 2019

Journal Articles

Minimal residual disease and stem cell transplantation outcomes

Jacqueline Cloos, Gert J. Ossenkoppele, Richard Dillon

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 617–625.

https://doi.org/10.1182/hematology.2019000006

Published: 2019

Journal Articles

In MDS, is higher risk higher reward?

Guillermo F. Sanz

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 381–390.

https://doi.org/10.1182/hematology.2019000042

Published: 2019

Journal Articles

Molecular profiling and management of mantle cell lymphoma

Jia Ruan

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 30–40.

https://doi.org/10.1182/hematology.2019000011

Published: 2019

Journal Articles

Delivering intensive therapies to older adults with hematologic malignancies: strategies to personalize care

Rebecca L. Olin

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 63–70.

https://doi.org/10.1182/hematology.2019001300

Published: 2019

Journal Articles

Where does transplant fit in the age of targeted therapies?

Victor A. Chow, Ajay K. Gopal

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 287–293.

https://doi.org/10.1182/hematology.2019000033

Published: 2019

Journal Articles

Microbiota modification in hematology: still at the bench or ready for the bedside?

Christopher J. Severyn, Ryan Brewster, Tessa M. Andermann

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 303–314.

https://doi.org/10.1182/hematology.2019000365

Published: 2019

Journal Articles

Treatment of primary immunodeficiency with allogeneic transplant and gene therapy

Sung-Yun Pai

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 457–465.

https://doi.org/10.1182/hematology.2019000052

Published: 2019

Journal Articles

How we perform haploidentical stem cell transplantation with posttransplant cyclophosphamide

Shannon R. McCurdy, Leo Luznik

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 513–521.

https://doi.org/10.1182/hematology.2019001323

Published: 2019

Journal Articles

Meeting the needs of CML patients in resource-poor countries

Hemant Malhotra, Jerald Radich, Pat Garcia-Gonzalez

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 433–442.

https://doi.org/10.1182/hematology.2019000050

Published: 2019

Journal Articles

Antibody-based therapies in patients with acute lymphoblastic leukemia

Shira Dinner, Michaela Liedtke

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 9–15.

https://doi.org/10.1182/asheducation-2018.1.9

Published: 2018

Journal Articles

Pharmacologic agents to prevent and treat relapse after allogeneic hematopoietic cell transplantation

Robert J. Soiffer, Yi-Bin Chen

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 699–707.

https://doi.org/10.1182/asheducation-2017.1.699

Published: 2017

Journal Articles

Minimal residual disease in adult ALL: technical aspects and implications for correct clinical interpretation

Monika Brüggemann, Michaela Kotrova

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 13–21.

https://doi.org/10.1182/asheducation-2017.1.13

Published: 2017

Journal Articles

Current management of Philadelphia chromosome positive ALL and the role of stem cell transplantation

Farhad Ravandi

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 22–27.

https://doi.org/10.1182/asheducation-2017.1.22

Published: 2017

Journal Articles

Extracorporeal photopheresis: cellular therapy for the treatment of acute and chronic graft-versus-host disease

Jennifer Schneiderman

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 639–644.

https://doi.org/10.1182/asheducation-2017.1.639

Published: 2017

Journal Articles

Inherited bone marrow failure syndromes: considerations pre- and posttransplant

Blanche P. Alter

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 88–95.

https://doi.org/10.1182/asheducation-2017.1.88

Published: 2017

Journal Articles

Cells to prevent/treat relapse following allogeneic stem cell transplantation

Andrew C. Dietz, Alan S. Wayne

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 708–715.

https://doi.org/10.1182/asheducation-2017.1.708

Published: 2017

Journal Articles

Pure red cell aplasia

Robert T. Means, Jr

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 51–56.

https://doi.org/10.1182/asheducation-2016.1.51

Published: 2016

NARROW

Opportunities for immunotherapy in childhood acute myeloid leukemia

Optimal disease management and health monitoring in adults with sickle cell disease

Clonal evolution and immune evasion in posttransplantation relapses

Minimal residual disease and stem cell transplantation outcomes

In MDS, is higher risk higher reward?

Molecular profiling and management of mantle cell lymphoma

Delivering intensive therapies to older adults with hematologic malignancies: strategies to personalize care

Where does transplant fit in the age of targeted therapies?

Microbiota modification in hematology: still at the bench or ready for the bedside?

Treatment of primary immunodeficiency with allogeneic transplant and gene therapy

How we perform haploidentical stem cell transplantation with posttransplant cyclophosphamide

Meeting the needs of CML patients in resource-poor countries

Antibody-based therapies in patients with acute lymphoblastic leukemia

Pharmacologic agents to prevent and treat relapse after allogeneic hematopoietic cell transplantation

Minimal residual disease in adult ALL: technical aspects and implications for correct clinical interpretation

Current management of Philadelphia chromosome positive ALL and the role of stem cell transplantation

Extracorporeal photopheresis: cellular therapy for the treatment of acute and chronic graft-versus-host disease

Inherited bone marrow failure syndromes: considerations pre- and posttransplant

Cells to prevent/treat relapse following allogeneic stem cell transplantation

Pure red cell aplasia

ASH Publications

American Society of Hematology

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only